Cite
HARVARD Citation
Sibaud, V. et al. (2022). Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed. Journal of the European Academy of Dermatology and Venereology. pp. e213-e215. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sibaud, V. et al. (2022). Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed. Journal of the European Academy of Dermatology and Venereology. pp. e213-e215. [Online].